SCHEMBL6535142

SCHEMBL6535142

Cc1c[nH]c(=O)c(-c2ccnc3ccccc23)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.58
TTK P33981 1/20 0.58
AURKB Q96GD4 1/20 0.58
INCENP Q9NQS7 1/20 0.58
ACVR1 Q04771 10/20 0.54
TGFBR1 P36897 3/20 0.50
BMPR1B O00238 1/20 0.50
RAF1 P04049 1/20 0.50
BRAF P15056 1/20 0.50
BMPR1A P36894 1/20 0.50
ACVR1B P36896 1/20 0.50
ACVRL1 P37023 1/20 0.50
NFATC1 O95644 1/20 0.47
DYRK1A Q13627 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
ESR1 P03372 1/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6535381 0.90 ACVR1 (0.55) AURKATTKAURKBINCENPACVR1
SCHEMBL23164291 0.79 MAPK14 (0.57) AURKATTKAURKBINCENPACVR1
SCHEMBL29830973 0.79 MAPK14 (0.57) AURKATTKAURKBINCENPACVR1
SCHEMBL6535782 0.76 MCL1 (0.50) MAPK14CA12PARP1CA9KDM4E
SCHEMBL27917128 0.74 CYP1A2 (0.60) TGFBR1NFATC1DYRK1ASMN1; SMN2NPC1
SCHEMBL29699887 0.74 CYP1A2 (0.60) TGFBR1NFATC1DYRK1ASMN1; SMN2NPC1
SCHEMBL1227713 0.74 CYP1A2 (0.60) TGFBR1NFATC1DYRK1ASMN1; SMN2NPC1
SCHEMBL7351998 0.73 AURKA (0.71) AURKATTKAURKBINCENPACVR1
SCHEMBL6535826 0.73 CHEK1 (0.46) TGFBR1SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL30487734 0.72 CYP1A2 (0.58) TGFBR1NFATC1DYRK1ASMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1261338-A4 COMPOSITIONS AND METHODS FOR TREATMENT OF EPILEPSY CYMAR INC (US) 2004-05-06 EP claimed
EP-1261338-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF EPILEPSY Cymar, Inc. (US) 2002-12-04 EP claimed
WO-2001062253-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF EPILEPSY CYMAR, INC. (US) 2001-08-30 WO claimed
EP-1261338-A4 COMPOSITIONS AND METHODS FOR TREATMENT OF EPILEPSY CYMAR INC (US) 2004-05-06 EP disclosed
EP-1261338-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF EPILEPSY Cymar, Inc. (US) 2002-12-04 EP disclosed
WO-2001062253-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF EPILEPSY CYMAR, INC. (US) 2001-08-30 WO disclosed